| CLS price and market capitalization | $331.44 close on July 31, 2026; $38.02 billion reported market cap; $330.00 after-hours | StockAnalysis.com quote | August 2, 2026 |
| Shares and market-cap verification | 114.98 million shares; $331.44 x 114.98 million = $38.11 billion, a 0.23 percent difference from the reported $38.02 billion | StockAnalysis.com and financial_rigor.py market-cap verification | August 2, 2026 |
| Q2 2026 revenue and net income | $4.699 billion revenue, up 62% from $2.893 billion; $368.8 million GAAP net income, confirmed by SEC EDGAR XBRL | Celestica Q2 2026 Form 10-Q and SEC EDGAR XBRL | August 2, 2026 |
| Q2 2026 adjusted results | Adjusted EPS $2.54, up 83%, beat $2.32 consensus by 9.5%; record 8.2% adjusted operating margin, up 80 basis points; adjusted gross margin 11.5%, down 20 basis points | Celestica Q2 2026 earnings release and call | August 2, 2026 |
| Q2 2026 segment results | CCS $3.81 billion, up 84%, 81% of revenue with 8.7% margin; communications up 62%, enterprise up 167%, HPS $1.9 billion up 58% at 41% of revenue; ATS $888 million, up 8%, 19% of revenue with 6.3% margin | Celestica Q2 2026 earnings call | August 2, 2026 |
| Customer concentration | Three customers each accounted for 10% or more of Q2 2026 revenue at 32%, 17%, and 14% | Celestica Q2 2026 earnings call | August 2, 2026 |
| Q3 2026 guidance | Revenue $5.25 billion to $5.55 billion, up 69% at midpoint; adjusted EPS $2.88 to $3.08, up 89% at midpoint; adjusted operating margin 8.4%; communications up about 60%, enterprise up about 190%, ATS mid-teens | Celestica Q2 2026 earnings call | August 2, 2026 |
| FY2026 raised outlook | Revenue raised to $20.5 billion from $19 billion, up 65%; adjusted EPS raised to $11.30 from $10.15, up 87%; adjusted operating margin 8.4% from 8.1%; free cash flow raised to $600 million; about $1 billion planned CapEx; CCS up about 85%, ATS up about 10% | Celestica Q2 2026 earnings call | August 2, 2026 |
| 2027 outlook | Revenue growth expected to accelerate beyond the 65% 2026 pace, with adjusted EPS growth outpacing revenue growth; OpenAI custom racks for the Jalapeno accelerator with Broadcom planned for mass production in 2027; AMD Helios scale-up a multi-billion dollar 2027 pipeline | Celestica Q2 2026 earnings call | August 2, 2026 |
| Q2 2026 cash flow | Free cash flow of $147 million in Q2 and $285 million year to date; CapEx of $264 million or 5.6% of revenue; cash cycle days of 47, down 19 year over year and 8 sequentially | Celestica Q2 2026 earnings call | August 2, 2026 |
| Cash and debt | $536 million cash and $740 million gross debt, net debt of $204 million as of June 30, 2026; gross debt to non-GAAP trailing 12-month adjusted EBITDA of 0.5x; about $2.3 billion available liquidity | Celestica Q2 2026 earnings call | August 2, 2026 |
| SEC EDGAR XBRL cash | $535.7 million cash and cash equivalents as of June 30, 2026 | SEC EDGAR XBRL company concept | August 2, 2026 |
| SEC EDGAR XBRL total debt | $810.4 million total debt including current maturities as of June 30, 2026, made up of $784.0 million long-term and $26.4 million current | SEC EDGAR XBRL company facts and Q2 2026 Form 10-Q | August 2, 2026 |
| H1 2026 results | H1 2026 revenue of $8.746 billion and net income of $581.1 million, confirmed by SEC EDGAR XBRL | Celestica Q2 2026 Form 10-Q and SEC EDGAR XBRL | August 2, 2026 |
| FY2025 results | $12.391 billion revenue, up 28.46%; net income of $832.5 million; EPS of $7.16; free cash flow of $458.3 million | Celestica FY2025 Form 10-K and StockAnalysis.com | August 2, 2026 |
| TTM financials | TTM revenue of $15.59 billion, net income of $1.12 billion, EPS of $9.62, operating cash flow of $1.14 billion, free cash flow of $518.7 million | StockAnalysis.com statistics | August 2, 2026 |
| Valuation check | 34.06x trailing EPS, 2.44x sales, 15.33x book value, 73.30x trailing free cash flow, EV/EBITDA of 24.63; financial_rigor.py computed 34.45x trailing EPS and 73.49x P/FCF | StockAnalysis.com statistics and financial_rigor.py | August 2, 2026 |
| Forward valuation | Forward PE near 29.1x on the 2026 consensus adjusted EPS of $11.38, and about 17x on the 2027 consensus of $19.46; the StockAnalysis statistics page shows 21.46x using a blended next-twelve-month estimate | StockAnalysis.com forecast and statistics | August 2, 2026 |
| Analyst consensus | Strong Buy with an average target of $471.70 across 20 analysts, low $385, median $485, and high $550, about 42% above the July 31 close | StockAnalysis.com forecast | August 2, 2026 |
| Analyst rating mix, July 2026 | 16 Strong Buy, 4 Buy, 1 Hold, 0 Sell, 0 Strong Sell out of 21 analysts | StockAnalysis.com forecast recommendation trends | August 2, 2026 |
| Recent analyst target updates | CIBC $480 to $500, Stifel $445 to $500, JPMorgan $445 to $485, Wolfe $425 to $475, BMO and Argus $450, RBC $440 to $450, UBS $400 to $410, Barclays $441 to $430 | StockAnalysis.com forecast and TipRanks | August 2, 2026 |
| 2026 and 2027 consensus estimates | FY2026 revenue estimate $20.56 billion with adjusted EPS $11.38; FY2027 revenue estimate $33.51 billion with adjusted EPS $19.46; FY2026 free cash flow estimate $650.51 million | StockAnalysis.com forecast | August 2, 2026 |
| Short interest | 3.02 million shares short, 2.65% of shares outstanding, 1.79 days to cover | StockAnalysis.com statistics short selling | August 2, 2026 |
| Technical snapshot | 20-day SMA near $335.21, 50-day SMA near $360.51, 100-day SMA near $350.94, 200-day SMA near $327.13, 14-day RSI near 47.64, 14-day ADX near 14.13, 14-day historical volatility near 97.76%, beta 1.52 | Barchart and StockAnalysis.com technical snapshots | August 2, 2026 |
| 52-week range | $173.23 to $474.03, with the $474.03 high reached on June 2, 2026 | StockAnalysis.com quote and history | August 2, 2026 |